GRAPH 1: Outpatient administration of Blinatumomab Infusion and Hematopoietic Stem Cell Transplantation as Treatment for Patients with Refractory Acute Lymphoblastic overall survival at 3 years follow up. 2015-2020. Hospital Infantil Teleton Oncologia.